NeuroHeal AI
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $130M
Overview
Applying AI/ML to accelerate drug discovery for neurological repair and regeneration.
Neuroscience
Technology Platform
A proprietary AI/ML platform that analyzes multimodal biological data to discover novel drug targets and therapeutic candidates for nerve repair and neurological disorders.
Funding History
1Total raised:$130M
Series A$130M
Opportunities
Potential to rapidly identify first-in-class mechanisms for nerve regeneration, a field with very few effective therapies.
Risk Factors
Risk that AI-generated hypotheses fail to translate into clinically effective therapies, which is common in neurology.
Competitive Landscape
Operates in the competitive AI-drug discovery sector but is specialized in the high-need, high-complexity field of neurological repair.